8-K: Cassava Sciences Enters Consulting Agreement with Former CEO Remi Barbier
Consulting Agreement Announcement
Cassava Sciences has engaged its former CEO, Remi Barbier, as a consultant for a one-year term, focusing on scientific research and product approvals.
Summary
- Cassava Sciences has entered into a consulting agreement with its former CEO, Remi Barbier, effective September 13, 2024.
- The agreement is for a one-year term, with a possible one-year extension at Cassava's discretion.
- Mr. Barbier will provide consulting services related to scientific research and obtaining governmental approvals for Cassava's products.
- He will be paid $100 per hour for his services.
- The agreement does not alter Mr. Barbier's existing severance benefits.
- Either party can terminate the agreement with 30 days' notice.
Sentiment
Score: 7
Explanation: The document is neutral to slightly positive. It indicates a continuation of a relationship with a key individual, but the terms are not overly generous. The agreement is expected and does not indicate any major positive or negative developments.
Positives
- Cassava retains access to Remi Barbier's expertise in scientific research and product approvals.
- The consulting agreement provides flexibility with a one-year term and a possible one-year extension.
- The hourly rate of $100 for consulting services is clearly defined.
- The agreement allows for termination by either party with 30 days' notice, providing flexibility.
- The agreement does not impact Mr. Barbier's existing severance benefits.
Negatives
- The agreement is non-exclusive, meaning Mr. Barbier could consult for other companies.
- The hourly rate of $100 may be considered low for a former CEO, potentially limiting his engagement.
- The agreement does not specify the expected number of hours of consulting services.
Risks
- The non-exclusive nature of the agreement could limit Mr. Barbier's availability.
- The hourly rate may not be sufficient to secure Mr. Barbier's full engagement.
- There is a risk that the consulting services may not be as effective as expected.
- The agreement could be terminated by either party with 30 days' notice, creating uncertainty.
Future Outlook
The consulting agreement may be extended for an additional year at Cassava's discretion, indicating a potential for continued collaboration.
Management Comments
- Cassava will retain Consultant to perform consulting services for the Company on a non-exclusive basis.
- Requests for Services will be communicated to Consultant by the Company's Principal Executive Officer or CFO, who will be Consultant's sole points of contact with the Company.
Industry Context
It is not uncommon for companies to engage former executives as consultants to leverage their expertise and knowledge, particularly in specialized fields like biotechnology.
Comparison to Industry Standards
- Consulting agreements with former CEOs are common in the biotech industry, often involving hourly or project-based fees.
- The hourly rate of $100 is relatively low compared to typical consulting rates for former CEOs, which can range from several hundred to over a thousand dollars per hour.
- The non-exclusive nature of the agreement is standard, allowing consultants to work with multiple clients.
- The one-year term with a potential extension is a typical structure for consulting engagements.
Stakeholder Impact
- Shareholders may view the consulting agreement positively as it retains valuable expertise.
- Employees may see the agreement as a sign of stability and continuity.
- The agreement may have a neutral impact on customers and suppliers.
Next Steps
- Remi Barbier will begin providing consulting services to Cassava Sciences.
- Cassava will monitor the effectiveness of the consulting services.
- Cassava may decide to extend the consulting agreement for an additional year.
Key Dates
| Date | Description |
|---|---|
| July 1, 1998 | Date of the original Employment Agreement between Cassava and Remi Barbier. |
| October 4, 2001 | Date of the Confidential Information and Invention Agreement between Cassava and Remi Barbier. |
| December 17, 2008 | Amendment date of the Employment Agreement. |
| June 20, 2013 | Amendment date of the Employment Agreement. |
| June 6, 2014 | Date of one of the stock option agreements granted to Remi Barbier. |
| November 14, 2014 | Date of one of the stock option agreements granted to Remi Barbier. |
| December 11, 2015 | Date of one of the stock option agreements granted to Remi Barbier. |
| August 23, 2017 | Date of one of the stock option agreements granted to Remi Barbier. |
| September 28, 2018 | Date of one of the stock option agreements granted to Remi Barbier. |
| December 13, 2019 | Date of one of the stock option agreements granted to Remi Barbier. |
| December 10, 2021 | Date of the Indemnification Agreement between Cassava and Remi Barbier. |
| October 3, 2023 | Date of one of the stock option agreements granted to Remi Barbier. |
| May 20, 2024 | Date of one of the stock option agreements granted to Remi Barbier. |
| July 15, 2024 | Date Remi Barbier resigned as President and CEO of Cassava Sciences. |
| July 17, 2024 | Date of the 8-K filing describing Mr. Barbier's severance benefits. |
| September 13, 2024 | Effective date of the Consulting Agreement and end of Remi Barbier's employment. |
| September 12, 2025 | End date of the initial one-year term of the Consulting Agreement. |
| September 17, 2024 | Date of the 8-K filing announcing the Consulting Agreement. |
Keywords
consulting agreement, Remi Barbier, Cassava Sciences, scientific research, product approvals, former CEO, hourly rate, severance benefits
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.